NZ544330A - Sulfonamide substituted imidazoquinolines - Google Patents
Sulfonamide substituted imidazoquinolinesInfo
- Publication number
- NZ544330A NZ544330A NZ544330A NZ54433004A NZ544330A NZ 544330 A NZ544330 A NZ 544330A NZ 544330 A NZ544330 A NZ 544330A NZ 54433004 A NZ54433004 A NZ 54433004A NZ 544330 A NZ544330 A NZ 544330A
- Authority
- NZ
- New Zealand
- Prior art keywords
- imidazo
- quinolin
- amino
- butyl
- mmol
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US48320003P | 2003-06-27 | 2003-06-27 | |
| PCT/US2004/020607 WO2005003065A2 (fr) | 2003-06-27 | 2004-06-25 | Imidazo-quinolines a substitution sulfonamide |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ544330A true NZ544330A (en) | 2009-06-26 |
Family
ID=33563911
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ544330A NZ544330A (en) | 2003-06-27 | 2004-06-25 | Sulfonamide substituted imidazoquinolines |
Country Status (16)
| Country | Link |
|---|---|
| EP (1) | EP1638566A4 (fr) |
| JP (1) | JP2007521280A (fr) |
| KR (1) | KR20060035637A (fr) |
| CN (1) | CN1812789B (fr) |
| AR (2) | AR044923A1 (fr) |
| AU (1) | AU2004253929A1 (fr) |
| BR (1) | BRPI0411916A (fr) |
| CA (1) | CA2529322A1 (fr) |
| IL (1) | IL172427A0 (fr) |
| MX (1) | MXPA06000144A (fr) |
| MY (1) | MY157827A (fr) |
| NZ (1) | NZ544330A (fr) |
| RU (1) | RU2374246C2 (fr) |
| TW (2) | TW200511992A (fr) |
| WO (2) | WO2005003064A2 (fr) |
| ZA (1) | ZA200600769B (fr) |
Families Citing this family (44)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040265351A1 (en) | 2003-04-10 | 2004-12-30 | Miller Richard L. | Methods and compositions for enhancing immune response |
| JP2007502293A (ja) | 2003-08-12 | 2007-02-08 | スリーエム イノベイティブ プロパティズ カンパニー | ヒドロキシルアミン置換イミダゾ含有化合物 |
| RU2006105101A (ru) | 2003-08-27 | 2007-10-10 | 3М Инновейтив Пропертиз Компани (US) | Арилокси и арилалкиленокси замещенные имидазохинолины |
| CA2537763A1 (fr) | 2003-09-05 | 2005-03-17 | 3M Innovative Properties Company | Traitement pour le lymphome a cellules b cd5<sp>+</sp> |
| US7544697B2 (en) | 2003-10-03 | 2009-06-09 | Coley Pharmaceutical Group, Inc. | Pyrazolopyridines and analogs thereof |
| MY146124A (en) | 2003-10-03 | 2012-06-29 | 3M Innovative Properties Co | Pyrazolopyridines and analogs thereof |
| AU2004278014B2 (en) | 2003-10-03 | 2011-04-28 | 3M Innovative Properties Company | Alkoxy substituted imidazoquinolines |
| US8598192B2 (en) | 2003-11-14 | 2013-12-03 | 3M Innovative Properties Company | Hydroxylamine substituted imidazoquinolines |
| JP2007511527A (ja) | 2003-11-14 | 2007-05-10 | スリーエム イノベイティブ プロパティズ カンパニー | オキシム置換イミダゾ環化合物 |
| WO2005051317A2 (fr) | 2003-11-25 | 2005-06-09 | 3M Innovative Properties Company | Systèmes cycliques d'imidazo substitués et procédés |
| US8940755B2 (en) * | 2003-12-02 | 2015-01-27 | 3M Innovative Properties Company | Therapeutic combinations and methods including IRM compounds |
| WO2005066170A1 (fr) | 2003-12-29 | 2005-07-21 | 3M Innovative Properties Company | Imidazoquinolines a substitution arylalcenyle et arylalkynyle |
| CA2551399A1 (fr) | 2003-12-30 | 2005-07-21 | 3M Innovative Properties Company | Sulfonamides d'imidazoquinolinyle, d'imidazopyridinyle et d'imidazonaphtyridinyle |
| US8697873B2 (en) | 2004-03-24 | 2014-04-15 | 3M Innovative Properties Company | Amide substituted imidazopyridines, imidazoquinolines, and imidazonaphthyridines |
| US8017779B2 (en) | 2004-06-15 | 2011-09-13 | 3M Innovative Properties Company | Nitrogen containing heterocyclyl substituted imidazoquinolines and imidazonaphthyridines |
| US8026366B2 (en) | 2004-06-18 | 2011-09-27 | 3M Innovative Properties Company | Aryloxy and arylalkyleneoxy substituted thiazoloquinolines and thiazolonaphthyridines |
| US8541438B2 (en) | 2004-06-18 | 2013-09-24 | 3M Innovative Properties Company | Substituted imidazoquinolines, imidazopyridines, and imidazonaphthyridines |
| US7897609B2 (en) | 2004-06-18 | 2011-03-01 | 3M Innovative Properties Company | Aryl substituted imidazonaphthyridines |
| US7915281B2 (en) | 2004-06-18 | 2011-03-29 | 3M Innovative Properties Company | Isoxazole, dihydroisoxazole, and oxadiazole substituted imidazo ring compounds and method |
| JP5543068B2 (ja) | 2004-12-30 | 2014-07-09 | スリーエム イノベイティブ プロパティズ カンパニー | キラル縮合［１，２］イミダゾ［４，５−ｃ］環状化合物 |
| EP1830880A4 (fr) * | 2004-12-30 | 2008-03-26 | Coley Pharm Group Inc | Administration par voies multiples de composes modificateurs de reponse immunitaire |
| JP5313502B2 (ja) | 2004-12-30 | 2013-10-09 | スリーエム イノベイティブ プロパティズ カンパニー | 置換キラル縮合［１，２］イミダゾ［４，５−ｃ］環状化合物 |
| JP2008530022A (ja) | 2005-02-04 | 2008-08-07 | コーリー ファーマシューティカル グループ，インコーポレイテッド | 免疫反応調節物質を含む水性ゲル処方物 |
| EP1846419B1 (fr) | 2005-02-09 | 2014-04-16 | 3M Innovative Properties Company | Thiazoloquinolines et thiazolonaphthyridines à substitution alcoxy |
| AU2006213746A1 (en) | 2005-02-11 | 2006-08-17 | Coley Pharmaceutical Group, Inc. | Oxime and hydroxylamine substituted imidazo(4,5-c) ring compounds and methods |
| WO2006107853A2 (fr) | 2005-04-01 | 2006-10-12 | Coley Pharmaceutical Group, Inc. | Pyrazolopyridine-1,4-diamines et analogues associes |
| AU2006232375A1 (en) | 2005-04-01 | 2006-10-12 | Coley Pharmaceutical Group, Inc. | 1-substituted pyrazolo (3,4-c) ring compounds as modulators of cytokine biosynthesis for the treatment of viral infections and neoplastic diseases |
| ZA200803029B (en) | 2005-09-09 | 2009-02-25 | Coley Pharm Group Inc | Amide and carbamate derivatives of alkyl substituted /V-[4-(4-amino-1H-imidazo[4,5-c] quinolin-1-yl)butyl] methane-sulfonamides and methods |
| CA2621831A1 (fr) | 2005-09-09 | 2007-03-15 | Coley Pharmaceutical Group, Inc. | Derives amide et carbamate de n-{2-[4-amino-2-(ethoxymethyl)-1h-imidazo[4,5-c]quinolin-1-yl]-1,1-dimethylethyl}methanesulfonamide et procedes associes |
| EP1937683A4 (fr) * | 2005-09-23 | 2010-08-25 | Coley Pharm Group Inc | Procede de preparation de 1h-imidazoý4,5-c¨pyridines et d'analogues de ceux-ci |
| EP3085373A1 (fr) | 2006-02-22 | 2016-10-26 | 3M Innovative Properties Company | Conjugués de modificateur de réponse immunitaire |
| WO2008008432A2 (fr) | 2006-07-12 | 2008-01-17 | Coley Pharmaceutical Group, Inc. | Composés à cycle [1,2] imidazo [4,5-c] fusionné chiral substitué et procédés correspondants |
| NZ588183A (en) * | 2008-03-24 | 2012-05-25 | 4Sc Discovery Gmbh | Novel substituted imidazoquinolines |
| ES2617451T3 (es) | 2010-08-17 | 2017-06-19 | 3M Innovative Properties Company | Composiciones lipidadas de compuestos modificadores de la respuesta inmunitaria, formulaciones, y métodos |
| EP3366311B1 (fr) | 2011-06-03 | 2020-02-26 | 3M Innovative Properties Co. | Hydrazino-1h-imidazoquinoléine-4-amines et conjugués obtenus à partir de celles-ci |
| WO2012167088A1 (fr) | 2011-06-03 | 2012-12-06 | 3M Innovative Properties Company | Lieurs hétérobifonctionnels comportant de segments de polyéthylène glycol et conjugués modificateurs de réponse immunitaire obtenus à partir de ceux-ci |
| JP6487921B2 (ja) | 2013-12-17 | 2019-03-20 | ファイザー・インク | ＬＲＲＫ２阻害薬としての新規の３，４−二置換−１Ｈ−ピロロ［２，３−ｂ］ピリジンおよび４，５−二置換−７Ｈ−ピロロ［２，３−ｃ］ピリダジン |
| MX2018003215A (es) * | 2015-09-14 | 2018-06-08 | Pfizer | Derivados de imidazo[4,5-c]quinolina e imidazo[4,5-c][1,5]naftirid ina novedosos como inhibidores de lrrk2. |
| WO2018009916A1 (fr) | 2016-07-07 | 2018-01-11 | The Board Of Trustees Of The Leland Stanford Junior University | Conjugués d'adjuvant d'anticorps |
| CA3056030A1 (fr) | 2017-03-10 | 2018-09-13 | Pfizer Inc. | Nouveaux derives imidazo[4,5-c]quinoleine utilises en tant qu'inhibiteurs de lrrk2 |
| LT3679025T (lt) | 2017-09-06 | 2022-06-27 | BioNTech SE | Pakeistieji imidazochinolinai, kaip tlr7 agonistai |
| JP7197244B2 (ja) | 2017-12-20 | 2022-12-27 | スリーエム イノベイティブ プロパティズ カンパニー | 免疫応答調節剤として使用するための分岐鎖連結基を有するアミド置換イミダゾ［４，５－ｃ］キノリン化合物 |
| JP2022525594A (ja) | 2019-03-15 | 2022-05-18 | ボルト バイオセラピューティクス、インコーポレーテッド | Ｈｅｒ２を標的とする免疫結合体 |
| EP4076445A1 (fr) * | 2019-12-20 | 2022-10-26 | Nammi Therapeutics, Inc. | Compositions liposomales formulées et/ou co-formulées contenant des promédicaments agonistes de récepteurs de type toll (« tlr ») utiles dans le traitement du cancer et méthodes associées |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6331539B1 (en) * | 1999-06-10 | 2001-12-18 | 3M Innovative Properties Company | Sulfonamide and sulfamide substituted imidazoquinolines |
| JP2005513021A (ja) * | 2001-11-16 | 2005-05-12 | スリーエム イノベイティブ プロパティズ カンパニー | Ｉｒｍ化合物およびトール様受容体経路に関する方法および組成物 |
| US6677349B1 (en) * | 2001-12-21 | 2004-01-13 | 3M Innovative Properties Company | Sulfonamide and sulfamide substituted imidazoquinolines |
-
2004
- 2004-06-24 MY MYPI20042461A patent/MY157827A/en unknown
- 2004-06-25 RU RU2005138915/04A patent/RU2374246C2/ru not_active IP Right Cessation
- 2004-06-25 WO PCT/US2004/020606 patent/WO2005003064A2/fr not_active Application Discontinuation
- 2004-06-25 CA CA002529322A patent/CA2529322A1/fr not_active Abandoned
- 2004-06-25 EP EP04756208A patent/EP1638566A4/fr not_active Withdrawn
- 2004-06-25 MX MXPA06000144A patent/MXPA06000144A/es unknown
- 2004-06-25 WO PCT/US2004/020607 patent/WO2005003065A2/fr active Application Filing
- 2004-06-25 KR KR1020057024904A patent/KR20060035637A/ko not_active Application Discontinuation
- 2004-06-25 NZ NZ544330A patent/NZ544330A/en unknown
- 2004-06-25 AR ARP040102248A patent/AR044923A1/es unknown
- 2004-06-25 AR ARP040102247A patent/AR044922A1/es unknown
- 2004-06-25 CN CN2004800181459A patent/CN1812789B/zh not_active Expired - Fee Related
- 2004-06-25 BR BRPI0411916-9A patent/BRPI0411916A/pt not_active IP Right Cessation
- 2004-06-25 JP JP2006517711A patent/JP2007521280A/ja active Pending
- 2004-06-25 TW TW093118636A patent/TW200511992A/zh unknown
- 2004-06-25 AU AU2004253929A patent/AU2004253929A1/en not_active Abandoned
- 2004-06-25 TW TW093118635A patent/TW200514784A/zh unknown
-
2005
- 2005-12-07 IL IL172427A patent/IL172427A0/en unknown
-
2006
- 2006-01-26 ZA ZA200600769A patent/ZA200600769B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP2007521280A (ja) | 2007-08-02 |
| TW200514784A (en) | 2005-05-01 |
| KR20060035637A (ko) | 2006-04-26 |
| WO2005003065A3 (fr) | 2005-03-10 |
| WO2005003065A2 (fr) | 2005-01-13 |
| IL172427A0 (en) | 2006-04-10 |
| CN1812789A (zh) | 2006-08-02 |
| AU2004253929A1 (en) | 2005-01-13 |
| WO2005003064A3 (fr) | 2005-03-31 |
| BRPI0411916A (pt) | 2006-08-15 |
| AR044922A1 (es) | 2005-10-12 |
| TW200511992A (en) | 2005-04-01 |
| CN1812789B (zh) | 2010-07-14 |
| AR044923A1 (es) | 2005-10-12 |
| RU2374246C2 (ru) | 2009-11-27 |
| EP1638566A4 (fr) | 2009-03-25 |
| EP1638566A2 (fr) | 2006-03-29 |
| RU2005138915A (ru) | 2006-06-27 |
| CA2529322A1 (fr) | 2005-01-13 |
| MY157827A (en) | 2016-07-29 |
| MXPA06000144A (es) | 2006-04-07 |
| WO2005003064A2 (fr) | 2005-01-13 |
| ZA200600769B (en) | 2007-05-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NZ544330A (en) | Sulfonamide substituted imidazoquinolines | |
| US6677349B1 (en) | Sulfonamide and sulfamide substituted imidazoquinolines | |
| US6331539B1 (en) | Sulfonamide and sulfamide substituted imidazoquinolines | |
| AU2002232482B2 (en) | Amido ether substituted imidazoquinolines | |
| AU766565B2 (en) | Urea substituted imidazoquinolines | |
| US20030130518A1 (en) | Urea substituted imidazoquinoline ethers | |
| AU2002232497A1 (en) | Urea substituted imidazoquinoline ethers | |
| CZ20031593A3 (cs) | Substituované imidazopyridiny | |
| EP1642580A1 (fr) | Sulfonamides d' imidazoquinoline |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PSEA | Patent sealed | ||
| RENW | Renewal (renewal fees accepted) |